Updated outcomes from STAMP: Surgically treated adjuvant Merkel cell carcinoma with pembrolizumab, a phase III trial—ECOG-ACRIN EA6174.

Authors

• Gary I. Cohen, Greater Baltimore Medical Center (GBMC)

Document Type

Article

Publication Title

Journal of Clinical Oncology

DOI

https://doi.org/10.1200/JCO.2026.44.17_suppl.LBA9505

Publication Date

6-3-2026

Recommended Citation

Janice M. Mehnert et al. Updated outcomes from STAMP: Surgically treated adjuvant Merkel cell carcinoma with pembrolizumab, a phase III trial—ECOG-ACRIN EA6174.. J Clin Oncol 44, LBA9505-LBA9505(2026).